Insight journal, Insight journal - Company

Abbvie: M&A activity 2009-2014

Posted on 25 June 2014

Tags: , ,

Abbvie has acquired only one company in 2010 with the purchase of Facet Biotechnology valued at $722 million.

This acquisition exploits Facet’s promising biologics technology intended to treat multiple sclerosis and complements Abbvie’s diverse oncology program.

Very recently in June 2014, Abbvie expressed interest in purchasing Shire but the proposal was rejected after several rounds of meeting.

Our report provides more detailed insight into the details of each deal. See: Report: Partnering Agreements with Abbvie 2009-2014

Full details on each deal can be found at Current Agreements (subscription required)

More

Summary profile data for Abbvie

Partnering interests for Abbvie

Partnering activity for Abbvie

 

Available reports from Current Partnering

Report: Partnering Agreements with Abbvie 2009-2014

Report: Top 50 Big Pharma Partnering and M&A Deal Trends     

 

Available resources for deal coverage for Abbvie          

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Read: more on Abbvie company profile, recent partnering, M&A and financing news and articles

 

Related

Report: Licensing Terms and Agreements in Pharma, Biotech and Diagnostics

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk

Follow us on:LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply